Microgen plc announced today that ABN AMRO Futures Ltd has purchased a license for Microgen Cortex+.
Microgen Cortex+ is the next generation of web enabled derivatives software and provides a comprehensive global trading solution, which is configured to operate effectively in most commodity exchanges worldwide. ABN AMRO Futures Ltd originally selected Cortex as the platform for delivering key operational functionality as a core OTC commodity trading and back office solution.
"We are delighted that ABN AMRO Futures Ltd have chosen Cortex+ to meet their future commodity trading and back office requirements." Said James Betteridge: Microgen Banking Systems "Cortex+ has been redeveloped using Microgen Aptitude enabling the business to gain greater access to information and improved workflow processing within a real time business environment," he concluded.
The Cortex+ architecture, user workflow and management statistics reporting are essential in minimising operational risk and enable organizations to meet aggressive matching and processing timeframes.
"We were looking for a flexible open web based solution which delivered performance and offered greater functionality to support the growing legislative requirements," said John Baron ABN AMRO Futures Ltd "Microgen Cortex+ meets the core objectives of ABN AMRO Futures with its comprehensive trading and back office processing. The additional "real-time" exception processing and management statistics reports will greater assist the business with these necessary controls for improving the operational performance within the business," he concluded. Microgen is offering its existing clients and prospective clients a phased migration strategy. This strategy allows clients to easily integrate each phase of the delivery, enabling clients to become accustomed to the new product, reducing the risk associated with upgrading a mission critical system.